Explore BrainMass
Share

Explore BrainMass

    Biotechnological Failures

    This content was COPIED from BrainMass.com - View the original, and get the already-completed solution here!

    Search of media reports on apparent strategic failures in the health care or biotechnology industries (e.g. divestment of a business, layoff of a large proportion of the workforce, very large losses over several years).

    Pick one of the failure stories for which a substantial amount of information is available. Attempt to determine the cause of the failure. Was an inappropriate strategy selected in the first place? If so, exactly why was it inappropriate? Was a reasonably suitable strategy chosen, but then incompetently implemented? In exactly what ways was the implementation faulty? Need help with 600 words

    Include a minimum of three peer-reviewed references.

    © BrainMass Inc. brainmass.com October 10, 2019, 7:00 am ad1c9bdddf
    https://brainmass.com/health-sciences/issues-in-health-care-delivery/biotechnological-failures-strategy-564615

    Solution Preview

    Was an inappropriate strategy selected in the first place? If so, exactly why was it inappropriate? Was a reasonably suitable strategy chosen, but then incompetently implemented? In exactly what ways was the implementation faulty? Need help with 600 words

    http://www.forbes.com/sites/johnlamattina/2013/11/04/vertex-failure-shows-biotech-is-not-immune-to-big-pharma-type-layoffs/

    A failure story that has recently been in the media is the unexpected failure of one of the biotechnologies most promising companies, which was Vertex's Incivek drug. Vertex Pharmaceuticals Inc. was poised to become a major leader in the biotechnology industry because it had a successful run of winning drug approvals for 2½ heady years while also being able to cultivate their integrated research and commercial enterprise. The New England area was deemed to be the cornerstone of its highest-profile within the biotechnology community. This seemingly locked position atop ...

    Solution Summary

    This response addresses the failure of a major Biotechnological company and explains why it failed.

    $2.19